Skip to main content
Videos

The Fundamentals and Role of Antipsychotic TDM in Clinical Decision Making

The Fundamentals and Role of Antipsychotic TDM in Clinical Decision Making

First presented in October 2024 at the European Society of Clinical Pharmacy in Krakow, Poland

Description

Description:

Therapeutic Drug Monitoring (TDM) of oral and long-acting injectable (LAI) antipsychotic medications plays a critical role in optimizing patient care.  Dr. Schoretsanitis provides expert insights into key considerations when using antipsychotic medications, including the clinical decision-making process for transitioning to LAIs and monitoring strategies. In addition, this session explores how TDM supports personalized treatment strategies, improves clinical decision-making, and enhances patient outcomes.

Presenting Faculty:

Georgios Schoretsanitis, MD, PhD

  • Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of
    Psychiatry, University of Zurich; Zurich, Switzerland
  • Department of Psychiatry, The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks; New York, NY
  • Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell; Hempstead, NY

Additional Resources:

For additional handouts, questions, or inquiries, please contact hello@saladax.com or enter your email below!


Close Menu